Article

Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice.

Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
The American Journal of Human Genetics (impact factor: 10.6). 05/2007; 80(4):792-9. DOI:10.1086/513019 pp.792-9
Source: PubMed

ABSTRACT We report a female patient with a de novo balanced translocation, 46,X,t(X;2)(p11.2;q37)dn, who exhibits seizures, capillary abnormality, developmental delay, infantile hypotonia, and obesity. The 2q37 breakpoint observed in association with the seizure phenotype is of particular interest, because it lies near loci implicated in epilepsy in humans and mice. Fluorescence in situ hybridization mapping of the translocation breakpoints showed that no known genes are disrupted at Xp11.2, whereas diacylglycerol kinase delta (DGKD) is disrupted at 2q37. Expression studies in Drosophila and mouse suggest that DGKD is involved in central nervous system development and function. Electroencephalographic assessment of Dgkd mutant mice revealed abnormal epileptic discharges and electrographic seizures in three of six homozygotes. These findings implicate DGKD disruption by the t(X;2)(p11.2;q37)dn in the observed phenotype and support a more general role for DGKD in the etiology of seizures.

0 0
 · 
0 Bookmarks
 · 
34 Views

Keywords

2q37 breakpoint
 
abnormal epileptic discharges
 
capillary abnormality
 
central nervous system development
 
de novo balanced translocation
 
developmental delay
 
Dgkd mutant mice
 
diacylglycerol kinase delta
 
Electroencephalographic assessment
 
electrographic seizures
 
exhibits seizures
 
Expression studies
 
female patient
 
findings implicate DGKD disruption
 
general role
 
infantile hypotonia
 
particular interest
 
seizure phenotype
 
situ hybridization
 
translocation breakpoints